Hip soreness that changes your day needs an exam

Soreness that keeps returning deserves a closer look

Arrange a regular visit if the hip keeps waking you. Do the same when walking, dressing, or leaving a chair stays hard.

Tell the examiner whether soreness sits in your groin or on the bony outside. Explain what settles it, what worsens it, and when it started.

Old X-rays aren't required, though they may help. Bring them if you have them, but don't get a new scan before someone examines the hip.

Fever, a bad fall, or sudden weakness needs care now

Call the doctor that day when fever comes with heat and swelling at the hip. Use urgent care if the doctor can't be reached and you feel ill.

After a fall, go to the emergency room if weight can't go on the injured leg. Go now if one leg seems shorter or rests turned outward.

Night soreness needs a prompt exam when changing position doesn't settle it. New weakness or trouble controlling the bladder or bowels also belongs in the emergency room.

The exam should end with a clear next step

The examiner checks motion, strength, sore spots, and the way you walk. You'll hear whether the joint, the outer muscle cords, or the back seems more likely to hurt.

An exam can't promise that any treatment will ease the hip. It can tell you which choices fit the findings and which don't.

While waiting, avoid any move that sharply catches the hip. Try level walking or slow chair rises only when steps stay steady and the next morning isn't worse.

Write down any question that's easy to forget. QC Kinetix calls its licensed clinic staff medical providers; its regenerative care includes platelet-rich plasma, shortened to PRP, which comes from a blood sample spun until the platelets concentrate.

Sources

1. In a three-arm randomized trial of 204 people with MRI-confirmed gluteal tendinopathy, an eight-week physiotherapist-led education and exercise programme produced success on global rating of change in 51/66 participants at 8 weeks versus 38/65 for a single corticosteroid injection and 20/68 for wait-and-see. Education plus exercise beat the injection at 8 weeks (risk difference 19.9%) and still beat it at 52 weeks (20.4%).

   Mellor R, et al. — Education plus exercise versus corticosteroid injection use versus a wait and see approach on global outcome and pain from gluteal tendinopathy: prospective, single blinded, randomised clinical trial.. BMJ, 2018. DOI: 10.1136/bmj.k1662.

2. In a double-blind RCT of 80 patients with chronic gluteal tendinopathy, a single ultrasound-guided intratendinous PRP injection produced a significantly better modified Harris Hip Score at 12 weeks than a single corticosteroid injection (74.05 vs 67.13, P=.048), with 82% versus 56.7% reaching the minimal clinically important difference.

   Fitzpatrick J, et al. — The Effectiveness of Platelet-Rich Plasma Injections in Gluteal Tendinopathy: A Randomized, Double-Blind Controlled Trial Comparing a Single Platelet-Rich Plasma Injection With a Single Corticosteroid Injection.. American Journal of Sports Medicine, 2018. DOI: 10.1177/0363546517745525.

3. Bacterial septic arthritis of a native joint is a medical emergency with high morbidity and mortality; diagnosis is largely clinical and depends on timely diagnostic aspiration of the joint plus appropriate antibiotics. A hot, swollen, acutely painful joint - especially with fever or immunosuppression - is an emergency-department problem, not a clinic-appointment problem.

   Mathews CJ, et al. — Bacterial septic arthritis in adults.. The Lancet, 2010. DOI: 10.1016/S0140-6736(09)61595-6.

4. FDA states verbatim that regenerative medicine products including stem cells, stromal vascular fraction, umbilical cord blood, Wharton's jelly, amniotic fluid and exosomes have NOT been approved 'for the treatment of any orthopedic condition, such as osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain, or shoulder pain.' The only FDA-approved stem cell products in the United States are blood-forming (hematopoietic progenitor) cells derived from umbilical cord blood, approved only for disorders affecting blood production.

   U.S. Food and Drug Administration — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes.. FDA, 2026.

5. Pooled analysis of national joint registries (Australia and Finland, 215,676 hip replacements) put 25-year all-cause construct survival at 57.9% (95% CI 57.1-58.7); pooled case series gave 77.6% (95% CI 76.0-79.2). The authors conclude patients and surgeons can expect a hip replacement to last 25 years in around 58% of patients.

   Evans JT, et al. — How long does a hip replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up.. The Lancet, 2019. DOI: 10.1016/S0140-6736(18)31665-9.